Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Joseph Akers Insider Profile
4 Followers
Joseph Akers, Director at Titan Pharmaceuticals, holds 213.00K shares in Titan Pharmaceuticals (Ticker: TTNP). Most recently, Joseph Akers Bought $200,000 shares of Titan Pharmaceuticals on Sep 25, 2018 for an estimated value of 50.00K.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-68.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Joseph Akers holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 19, 2016 - Jul 19, 2017
Return:-59.30%
The most profitable trade made by Joseph Akers
Joseph Akers's Trading History
List of latest transactions for each holding click on a transaction to see Joseph Akers's performance on stock
You May Also Like
Joseph Akers insider profile FAQ
What is the percentage of profitable transactions made by Joseph Akers?
The percentage of profitable transactions made by Joseph Akers is 0%.
What is the average return per transaction made by Joseph Akers?
The average return per transaction made by Joseph Akers is -68.10%.
What stocks does Joseph Akers hold?
Joseph Akers holds: TTNP stocks.
What was Joseph Akers’s latest transaction?
Joseph Akers latest transaction was an Informative Buy of $50.00K.
What was Joseph Akers's most profitable transaction?
Joseph Akers’s most profitable transaction was an Informative Buy of TTNP stock on July 19, 2016. The return on the trade was -59.30%.
What is Joseph Akers's role in Titan Pharmaceuticals?
Joseph Akers's role in Titan Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.